Bell Rose Capital Inc

Bell Rose Capital’s new partnership with 4biddenknowledge Inc. boosts the 2026 FilmFaster48 festival’s marketing, distribution and creator outreach—showcasing a bold pivot from pharma to creative growth.

Bell Rose Capital Inc. develops anti‑viral drugs for Hep C and HIV/AIDS while launching AI‑powered logistics platform LENIE, yet its stock remains highly volatile and low‑liquidity, prompting investor caution.

Bell Rose Capital Inc. is a U.S.-based company specializing in pharmaceuticals for viral infections, with a focus on research and development of anti-viral therapies.